Mitsubishi Ufj Trust & Banking Corp Staar Surgical CO Transaction History

Mitsubishi Ufj Trust & Banking Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$38.07 - $52.25 $672,278 - $922,682	-17,659 Reduced 17.38%	83,947 $4 Million
Q1 2024 May 10, 2024	SELL	$27.67 - $39.61 $263,252 - $376,849	-9,514 Reduced 8.56%	101,606 $3.89 Million
Q4 2023 Feb 09, 2024	SELL	$30.6 - $43.78 $322,830 - $461,879	-10,550 Reduced 8.67%	111,120 $3.47 Million
Q3 2023 Nov 09, 2023	SELL	$39.39 - $58.12 $79,567 - $117,402	-2,020 Reduced 1.63%	121,670 $4.89 Million
Q2 2023 Aug 08, 2023	SELL	$50.45 - $72.82 $311,276 - $449,299	-6,170 Reduced 4.75%	123,690 $6.5 Million
Q1 2023 May 10, 2023	SELL	$51.25 - $79.34 $755,937 - $1.17 Million	-14,750 Reduced 10.2%	129,860 $8.3 Million
Q4 2022 Feb 10, 2023	SELL	$46.82 - $76.2 $358,173 - $582,930	-7,650 Reduced 5.02%	144,610 $7.02 Million
Q3 2022 Nov 10, 2022	SELL	$70.55 - $111.58 $61,378 - $97,074	-870 Reduced 0.57%	152,260 $10.7 Million
Q2 2022 Aug 09, 2022	SELL	$50.24 - $80.48 $79,881 - $127,963	-1,590 Reduced 1.03%	153,130 $10.9 Million
Q1 2022 May 12, 2022	SELL	$57.98 - $93.5 $111,321 - $179,520	-1,920 Reduced 1.23%	154,720 $12.4 Million
Q4 2021 Feb 09, 2022	SELL	$88.02 - $127.79 $1.38 Million - $2 Million	-15,640 Reduced 9.08%	156,640 $14.3 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $162.68 $454,175 - $601,916	-3,700 Reduced 2.1%	172,280 $22.1 Million
Q2 2021 Aug 12, 2021	BUY	$105.76 - $154.96 $16.5 Million - $24.2 Million	156,440 Added 800.61%	175,980 $26.8 Million
Q1 2021 May 12, 2021	BUY	$78.5 - $126.48 $1.53 Million - $2.47 Million	19,540 New	19,540 $2.06 Million

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.